Latest News about RGNX
Recent news which mentions RGNX
Regenxbio Says Diabetic Retinopathy Gene Therapy Shows Meaningful Improvements In Disease Severity
November 03, 2022
Tickers
RGNX
From Benzinga
Earnings Scheduled For November 3, 2022
November 03, 2022
From Benzinga
Despite Solid Efficacy From Gene Therapy, This Analyst Cuts REGENXBIO's Price Target
October 04, 2022
Tickers
RGNX
From Benzinga
Alphabet To $114? Plus This Analyst Predicts $145 For Disney
October 04, 2022
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 03, 2022
From Benzinga
From Benzinga
From Benzinga
5 Small-Cap S&P Stocks To Buy With The Most Upside
May 26, 2022
From Benzinga
From Benzinga
5 Value Stocks In The Healthcare Sector
May 16, 2022
From Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
May 16, 2022
From Benzinga
From Benzinga
83 Biggest Movers From Yesterday
May 06, 2022
From Benzinga
57 Stocks Moving In Thursday's Mid-Day Session
May 05, 2022
From Benzinga
From Benzinga
3 Small-Cap Medical Stocks With Big Momentum
April 27, 2022
From Motley Fool
7 Top-Rated Biotech Stocks to Buy for Q2
April 21, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
